Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Male hormones may increase the severity and death rates of COVID-19.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

Gender and social factors, not just biology, affect COVID-19 death rates.

Older age and existing health conditions increase COVID-19 death risk.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Men had worse COVID-19 outcomes than women in New York City.

Racial minorities faced more Covid-19 blame due to anti-fatness and structural racism.

Vaccination is crucial for managing Covid-19 despite new virus strains.

Age, health conditions, race, and gender affect COVID-19 risk.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Asthma and high testosterone increase Covid-19 severity, while progesterone protects young women.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.